Baxter Establishes Cambridge R&D Site … | Chemical & Engineering News
Volume 92 Issue 40 | p. 21 | Concentrates
Issue Date: October 6, 2014

Baxter Establishes Cambridge R&D Site …

Department: Business
Keywords: pharmaceuticals, biosimilars, R&D

In advance of spinning off its biopharmaceuticals business, Baxter is establishing an R&D center in Cambridge, Mass., for the new company. To become stand-alone in mid-2015, the new firm, Baxalta, will focus on hematology, immunology, gene therapy, and biosimilars. Some 400 scientists will be based at the R&D center, alongside Baxalta’s business development, oncology, and biosimilars teams. Baxalta will continue R&D in Vienna, Austria, but some R&D positions from California and Austria will relocate to Massachusetts.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment